Arrowhead Research Corporation Axolabs GmbH Company Profile
Arrowhead Research Corporation is a clinical stage nanomedicine company developing innovative therapies at the interface of biology and nanoengineering. Arrowheadâs world-class capabilities and intellectual property covering nucleic acid delivery, siRNA chemistry, and tissue targeting allow it to design and develop therapeutic agents for a wide range of diseases. The companyâs lead products include CALAA-01, an oncology drug candidate based on the gene silencing RNA interference (RNAi) mechanism, and AdipotideTM, an anti-obesity peptide that targets and kills the blood vessels that feed white adipose tissue. Arrowhead is leveraging its proprietary Dynamic PolyConjugateTM (DPC), Liposomal Nanoparticle (LNP), and RONDELTM delivery platforms to support its own pipeline of preclinical and clinical candidates and to secure external partnerships and collaborations with biotech and pharmaceutical companies. For more information, please visit www.arrowheadresearch.com.
News Articles
Arrowhead Research Corporation and Shire in a pact for peptide drug conjugates
Arrowhead Research Corporation has signed a research collaboration and license agreement with Shire , to develop and commercialize targeted peptide-drug conjugates by utilizing Arrowhead’s human-der...
Arrowhead Research Corporation announced that it entered into an agreement with Merck, through a subsidiary, to undertake an evaluation of a novel proprietary therapeutic monoclonal antibody candidate...
Arrowhead to raise $36M in private placement
Arrowhead Research Corp. (NASDAQ:ARWR) plans to raise $36 million through the sale of 14.3 million shares at $1.83 and 9,900 series B convertible preferred shares at $1,000 in a private placement. Eac...
Arrowhead Research scientists claim RNA delivery bull’s eye
Scientists from targeted therapeutics firm Arrowhead Research claim vesicle bursting polymer can overcome siRNA delivery difficulties.
[Arrowhead Research] licenses [Shire] rights to homing peptide platform
Rare disease drug developer [Shire PLC] has received a worldwide license to use [Arrowhead Research Corp.]’s (has compounds in development for cancer and metabolic and infectious diseases) human-der...
Edison - Arrowhead Research Corp - Financed to ARC-520 proof-of-concept data
Arrowhead’s $36m financing brings in much needed cash, as well as a group of biotech-specialist investors, which should move it up a league as it embarks on the clinical development of its hep...
Arrowhead Research's CEO Discusses F2Q13 Results - Earnings Call Transcript
Arrowhead Research Corporation (ARWR) F2Q13 Earnings Call May 9, 2013 4:30 PM ET Executives Vincent Anzalone – Director, Finance and IR Dr. Christopher Anzalone – President and CEO Dr. Bruce...
Arrowhead Research Corp improving focus, say Edison analysts
Last year's acquisition of Roche's RNAi (RNA interference) business (The Pharma Letter October 25, 2011) makes USA-based nano-medicine developer Arrowhead Research Corp (Nasdaq: ARWR) one of the leade...
Drugs and Medications
La mer the treatment fluid foundation [MAX HUBER RESEARCH LAB INC]
Alco-san instant skin sanitizer [Mid-American Chemical Research Corporation]
ALCO-SAN INSTANT SKIN SANITIZER
Sunscreen [CRC (Cosmoceutical Research Center)]
SUNSCREEN SPF 28/30
VioNexus No Rinse Spray
PubMed Articles
Bilateral Blurred Vision in a "Healthy" Adult.
A 40-year-old man presented with a 5-week history of headaches and blurred vision in both eyes, with no other medical history. He reported having no chest pain or shortness of breath. A physical exami...
A 10-year-old boy presented to the emergency department with increasing periumbilical and epigastric pain after a 3-week period of intermittent abdominal discomfort. After clinical evaluation, compute...
Saccadic inhibition of return can arise from late-stage execution processes.
Inhibition of return (IOR) is thought to improve the efficiency of visual search behaviour by biasing attention, eye movements, or both, toward novel stimuli. Previous research suggests that IOR might...
To examine racial/ethnic disparities in stage of disease and comorbidity (pre-treatment), surgical treatment allocation (breast-conserving surgery versus mastectomy), and in-hospital outcomes after su...
To examine the effect of comorbidity on risk of postoperative complications, prolonged hospitalization (defined as above median length of stay), non-routine disposition, and in-patient death among wom...
Clinical Trials
Research Participants' Views on the Ethics of Clinical Research
This pilot study will explore the usefulness of a series of questions asking about views of research from the perspective of minority and economically disadvantaged research participants....
Research Participants' Perceptions of Their Experience in Clinical Studies
This study will examine how research volunteers experience their participation in studies in order to develop surveys to be used by research centers trying to improve the experience of the...
Cultural Congruence in International Genetics Research
This study will explore how cultural differences influence genetics research in developing countries. Human genetics research is becoming more common in developing countries. However, when...
Background: - Understanding participants' experiences as research volunteers is critical to improving the effectiveness of human participant protection programs and strengthening...
Evaluation of TEACH (Training Early Achievers for Careers in Health) Research
The conceptual framework underlying the TEACH Research Program is based on a specific theoretical approach designed to influence adolescent career choice, in this case towards a career in...
Companies
Arrowhead Research Corporation Axolabs GmbH
Arrowhead Research Corporation is a clinical stage nanomedicine company developing innovative therapies at the interface of biology and nanoengineering. Arrowheadâs world-cla...
Arrowhead Research Corporation
Arrowhead Research Corporation (www.arrowheadresearch.com) (NASDAQ: ARWR) is a nanotechnology company commercializing new technologies in the areas of life sciences and electronic...
Arrowhead Electronic Healthcare, LLC
For over a decade, Arrowhead Electronic Healthcare, LLC has provided comprehensive ePRO solutions that help our pharmaceutical clients improve the health of people around the worl...
Arrowhead Publishers is a leader in business intelligence and market research reports for the pharmaceutical and biotech industries. Our reports offer readers a blend of information, insight, analysis...
More Information about "Arrowhead Research Corporation Axolabs GmbH" on BioPortfolio
We have published hundreds of Arrowhead Research Corporation Axolabs GmbH news stories on BioPortfolio along with dozens of Arrowhead Research Corporation Axolabs GmbH Clinical Trials and PubMed Articles about Arrowhead Research Corporation Axolabs GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Arrowhead Research Corporation Axolabs GmbH Companies in our database. You can also find out about relevant Arrowhead Research Corporation Axolabs GmbH Drugs and Medications on this site too.
